CDQ ST

Primær information

  • Handelsnavn:
  • CDQ ST Brusetablet
  • Lægemiddelform:
  • Brusetablet
  • Sammensætning:
  • 333,33 g/kg tribenuron-methyl; (~ 322 g/kg tribenuron; 166,67 g/kg metsulfuron-methyl; (~ 161 g/kg metsulfuron
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

Lokation

  • Fås i:
  • CDQ ST Brusetablet
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Sidste ændring:
  • 07-02-2018

Produktresumé

SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006

DPX-CDQ73 50ST

Version 2.0

Revision Date 12.10.2007

Ref. 130000035837

This SDS adheres to the standards and regulatory requirements of the European Community and may not meet the

regulatory requirements of other countries.

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

Product information

Product name

DPX-CDQ73 50ST

Use of the

Substance/Preparation

Herbicide

Company

DuPont International Operations S.a.r.l.

2, chemin du Pavillon

CH-1218 Le Grand-Saconnex / GE

Switzerland

+41-22-717.5111

Telefax

+41-22-717.6135

Emergency telephone

+44-(0)8456-006.640

E-mail address

sds-support@che.dupont.com

Supplier

Du Pont de Nemours (France) S.A.S.

82, rue de Wittelsheim

F-68701 Cernay Cedex

+33 3 89 38 38 38

2. HAZARDS IDENTIFICATION

Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.

3. COMPOSITION/INFORMATION ON INGREDIENTS

Chemical Name

CAS-No.

EC-No.

Classification

Concentration [%]

Tribenuron methyl

101200-48-0

401-190-1

N; R50/53

33,3

Metsulfuron methyl

74223-64-6

N; R50 -R53

16,7

Citric acid

77-92-9

201-069-1

Xi; R36/38

>= 5 - < 10

Magnesium stearate

557-04-0

209-150-3

Xi; R36/37/38

>= 1 - < 5

For the full text of the R phrases mentioned in this Section, see Section 16.

Print Date: 2008 - 2 - 21

SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006

DPX-CDQ73 50ST

Version 2.0

Revision Date 12.10.2007

Ref. 130000035837

4. FIRST AID MEASURES

General advice

Never give anything by mouth to an unconscious person.

Inhalation

Move to fresh air. Oxygen or artificial respiration if needed. Consult a physician.

Skin contact

Take off contaminated clothing and shoes immediately. Wash off immediately

with soap and plenty of water. In the case of skin irritation or allergic reactions

see a physician. Wash contaminated clothing before re-use.

Eye contact

Rinse thoroughly with plenty of water, also under the eyelids. Keep eye wide

open while rinsing. If eye irritation persists, consult a specialist.

Ingestion

Do not induce vomiting without medical advice. Obtain medical attention.

5. FIRE-FIGHTING MEASURES

Suitable extinguishing

media

Water spray, Dry chemical, Carbon dioxide (CO2),

Extinguishing media which

shall not be used for safety

reasons

High volume water jet, (contamination risk),

Special protective

equipment for fire-fighters

In the event of fire, wear self-contained breathing apparatus.

Further information

Prevent fire extinguishing water from contaminating surface water or the ground

water system. Collect contaminated fire extinguishing water separately. This

must not be discharged into drains. Fire residues and contaminated fire

extinguishing water must be disposed of in accordance with local regulations.

(on small fires) If area is heavily exposed to fire and if conditions permit, let fire

burn itself out since water may increase the area contaminated. Cool containers

/ tanks with water spray.

6. ACCIDENTAL RELEASE MEASURES

Personal precautions

Use personal protective equipment.

Environmental precautions

Prevent further leakage or spillage if safe to do so. Use appropriate container to

avoid environmental contamination. Do not flush into surface water or sanitary

sewer system. Do not allow material to contaminate ground water system. Local

authorities should be advised if significant spillages cannot be contained. If the

product contaminates rivers and lakes or drains inform respective authorities.

Methods for cleaning up

Clean-up methods - small spillage Sweep up or vacuum up spillage and collect

in suitable container for disposal.

Prevent further leakage or spillage. Use approved industrial vacuum cleaner for

removal. Shovel into suitable container for disposal.

Additional advice

Never return spills in original containers for re-use. Dispose of in accordance

Print Date: 2008 - 2 - 21

SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006

DPX-CDQ73 50ST

Version 2.0

Revision Date 12.10.2007

Ref. 130000035837

with local regulations.

7. HANDLING AND STORAGE

Handling

Advice on safe handling

Provide appropriate exhaust ventilation at places where dust is formed. Wear

personal protective equipment.

Storage

Requirements for storage

areas and containers

Keep containers tightly closed in a dry, cool and well-ventilated place. Store in a

place accessible by authorized persons only. Keep out of reach of children.

Keep away from food, drink and animal feeding stuffs.

Advice on common storage

No special restrictions on storage with other products.

Other data

: Stable under recommended storage conditions.

8. EXPOSURE CONTROLS / PERSONAL PROTECTION

Engineering measures

Ensure adequate ventilation, especially in confined areas.

Personal protective equipment

Respiratory protection

No personal respiratory protective equipment normally required.

Hand protection

Material: Nitrile rubber

Glove thickness: 0,4 - 0,7 mm

Wearing time: 480 min

Please observe the instructions regarding permeability and breakthrough time

which are provided by the supplier of the gloves. Also take into consideration the

specific local conditions under which the product is used, such as the danger of

cuts, abrasion, and the contact time., The suitability for a specific workplace

should be discussed with the producers of the protective gloves.

Eye protection

Safety glasses with side-shields conforming to EN166

Skin and body protection

Full protective clothing Type 4 (EN 14605)

Hygiene measures

Wash hands before breaks and immediately after handling the product. When

using do not eat, drink or smoke. Keep away from food, drink and animal

feeding stuffs. For environmental protection remove and wash all contaminated

protective equipment before re-use. Dispose of rinse water in accordance with

local and national regulations.

Protective measures

All chemical protective clothing should be visually inspected prior to use.

Clothing and gloves should be replaced in case of chemical or physical damage

or if contaminated.

Print Date: 2008 - 2 - 21

SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006

DPX-CDQ73 50ST

Version 2.0

Revision Date 12.10.2007

Ref. 130000035837

9. PHYSICAL AND CHEMICAL PROPERTIES

Form

tablet,

Colour

white,

Odour

slight, acrid,

Flash point

not applicable

Explosive properties

Not explosive

Water solubility

, soluble

10. STABILITY AND REACTIVITY

Conditions to avoid

: Exposure to moisture.

Hazardous decomposition

products

: Carbon oxides, nitrogen oxides (NOx)

Hazardous reactions

: Being an effervescent tablet, this product will react vigorously when in contact

with water.

11. TOXICOLOGICAL INFORMATION

Acute oral toxicity

• Tribenuron methyl

LD50/ rat : > 5 000 mg/kg

• Metsulfuron methyl

LD50/ rat : > 5 000 mg/kg

Acute inhalation toxicity

• Tribenuron methyl

LC50/ 4 h/ rat : > 6,0 mg/l

• Metsulfuron methyl

LC50/ 4 h/ rat : > 5,3 mg/l

Acute dermal toxicity

• Tribenuron methyl

LD50/ rat : > 5 000 mg/kg

• Metsulfuron methyl

LD50/ rabbit : > 2 000 mg/kg

Skin irritation

• Tribenuron methyl

rabbit

No skin irritation

• Metsulfuron methyl

rabbit

No skin irritation

Eye irritation

• Tribenuron methyl

rabbit

No eye irritation

• Metsulfuron methyl

rabbit

Print Date: 2008 - 2 - 21

SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006

DPX-CDQ73 50ST

Version 2.0

Revision Date 12.10.2007

Ref. 130000035837

No eye irritation

Sensitisation

Animal test did not cause sensitization by skin contact. (Data on the product

itself)

Mutagenicity assessment

Tribenuron methyl

Did not show mutagenic effects in animal experiments.

Metsulfuron methyl

Did not show mutagenic effects in animal experiments.

Carcinogenicity assessment

Tribenuron methyl

Did not show carcinogenic effects in animal experiments.

Metsulfuron methyl

Did not show carcinogenic effects in animal experiments.

Toxicity to reproduction assessment

Tribenuron methyl

Animal testing did not show any effects on fertility., Animal testing did not show

any effects on foetal development.

Metsulfuron methyl

Animal testing did not show any effects on fertility., Animal testing did not show

any effects on foetal development.

12. ECOLOGICAL INFORMATION

Toxicity to fish

• Tribenuron methyl

LC50 / 96 h/ Oncorhynchus mykiss (rainbow trout) : 738 mg/l

• Metsulfuron methyl

LC50 / 96 h/ Oncorhynchus mykiss (rainbow trout) : > 150 mg/l

Toxicity to algae

/ EbC50/ 72 h/ Selenastrum capricornutum: 0,018 mg/l

(Data on the product itself)

Aquatic toxicity

• Tribenuron methyl

/ EC50/ 48 h/ Daphnia magna (Water flea): > 894 mg/l

• Metsulfuron methyl

/ EC50/ 48 h/ Daphnia magna (Water flea): > 150 mg/l

13. DISPOSAL CONSIDERATIONS

Product

In accordance with local and national regulations. Must be incinerated in a

suitable incineration plant holding a permit delivered by the competent

authorities. Do not contaminate ponds, waterways or ditches with chemical or

used container.

Contaminated packaging

Do not re-use empty containers.

European Waste Catalogue

020108

Print Date: 2008 - 2 - 21

SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006

DPX-CDQ73 50ST

Version 2.0

Revision Date 12.10.2007

Ref. 130000035837

number

14. TRANSPORT INFORMATION

Class:

Packaging group:

Classification Code:

HI No::

UN-Number:

3077

Labelling No.:

Proper shipping name:

Environmentally hazardous substance, solid, n.o.s. (Tribenuron methyl, Metsulfuron

methyl)

Further information

Not classified as dangerous in the meaning of sea and air transport regulations.,

Optional classification as per IMDG Special Provision 909., Optional

classification as per IATA Special Provision A97.

15. REGULATORY INFORMATION

Labelling according to EC Directives

Symbol(s)

Dangerous for the environment

Hazardous components:

Metsulfuron methyl

Tribenuron methyl

R-phrase(s)

R50/53

Very toxic to aquatic organisms, may cause long-term

adverse effects in the aquatic environment.

S-phrase(s)

Keep out of reach of children.

Keep away from food, drink and animal feeding stuffs.

S20/21

When using do not eat, drink or smoke.

If swallowed, seek medical advice immediately and show this

container or label.

This material and its container must be disposed of in a safe

way.

Use appropriate container to avoid environmental

contamination.

SP 1

Do not contaminate water with the product or its container

(Do not clean application equipment near surface

water/Avoid contamination via drains from farmyards and

roads).

Special labelling of certain

preparations

To avoid risks to man and the environment, comply with the instructions for use.

Sensitising components

contains:

Tribenuron methyl

May produce an allergic reaction.

Print Date: 2008 - 2 - 21

SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006

DPX-CDQ73 50ST

Version 2.0

Revision Date 12.10.2007

Ref. 130000035837

16. OTHER INFORMATION

Text of R phrases mentioned in Section 3

R36/37/38

Irritating to eyes, respiratory system and skin.

R36/38

Irritating to eyes and skin.

May cause sensitization by skin contact.

Very toxic to aquatic organisms.

R50/53

Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic

environment.

May cause long-term adverse effects in the aquatic environment.

Further information

Take notice of the directions of use on the label.

Significant change from previous version is denoted with a double bar.

The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at

the date of its publication. The information given is designed only as a guidance for safe handling, use, processing,

storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The

above information relates only to the specific material(s) designated herein and may not be valid for such material(s)

used in combination with any other materials or in any process or if the material is altered or processed, unless

specified in the text.

Print Date: 2008 - 2 - 21

  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.



  • Dokumenter på andre sprog er tilgængelige her

18-10-2018

Scientific Opinion on Flavouring Group Evaluation 201 Revision 2 (FGE.201Rev2): 2‐alkylated, aliphatic, acyclic alpha,beta‐unsaturated aldehydes and precursors, with or without additional double‐bonds, from chemical subgroup 1.1.2 of FGE.19

Scientific Opinion on Flavouring Group Evaluation 201 Revision 2 (FGE.201Rev2): 2‐alkylated, aliphatic, acyclic alpha,beta‐unsaturated aldehydes and precursors, with or without additional double‐bonds, from chemical subgroup 1.1.2 of FGE.19

Published on: Wed, 17 Oct 2018 00:00:00 +0200 The Panel on Food Additives and Flavourings of the European Food Safety Authority was requested to consider in this revision 2 of Flavouring Group Evaluation 201, the additional data on genotoxicity submitted by the Industry on two substances, 2‐methylpent‐2‐enal [FL‐no: 05.090] and 2 methylcrotonaldehyde [FL‐no: 05.095], from subgroup 1.1.2 of FGE.19. In FGE.201Rev1, the Panel concluded that further data were required in order to clarify the genotoxic poten...

Europe - EFSA - European Food Safety Authority Publications

23-7-2018

Orphan designation:  Bardoxolone methyl,  for the: Treatment of Alport syndrome

Orphan designation: Bardoxolone methyl, for the: Treatment of Alport syndrome

Europe - EMA - European Medicines Agency

28-8-2018

EU/3/18/2055 (IQVIA RDS Ireland Limited)

EU/3/18/2055 (IQVIA RDS Ireland Limited)

EU/3/18/2055 (Active substance: (3R,3aS,9R,9aS,9bS)-3-((dimethylamino)methyl)-9-hydroxy-6,9-dimethyl-3,3a,4,5,7,8,9,9a-octahydroazuleno[4,5-b]furan-2(9bH)-one fumarate) - Orphan designation - Commission Decision (2018)5727 of Tue, 28 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/060/18

Europe -DG Health and Food Safety

27-7-2018

EU/3/18/2019 (Reata UK Limited)

EU/3/18/2019 (Reata UK Limited)

EU/3/18/2019 (Active substance: Bardoxolone methyl) - Transfer of orphan designation - Commission Decision (2018)5055 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/011/18/T/01

Europe -DG Health and Food Safety

27-7-2018

EU/3/06/401 (Pfizer Europe MA EEIG)

EU/3/06/401 (Pfizer Europe MA EEIG)

EU/3/06/401 (Active substance: N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium; 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate) - Transfer of orphan designation - Commission Decision (2018)5038 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/032/06/T/03

Europe -DG Health and Food Safety

29-6-2018

EU/3/18/2029 (Klinikum der UniversitAt MUnchen)

EU/3/18/2029 (Klinikum der UniversitAt MUnchen)

EU/3/18/2029 (Active substance: 2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one) - Orphan designation - Commission Decision (2018)4174 of Fri, 29 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/004/18

Europe -DG Health and Food Safety

29-6-2018

EU/3/18/2028 (BioCryst UK Ltd)

EU/3/18/2028 (BioCryst UK Ltd)

EU/3/18/2028 (Active substance: (R)-1-(3-(aminomethyl) phenyl)-N-(5-((3-cyanophenyl)(cyclopropylmethylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride) - Orphan designation - Commission Decision (2018)4173 of Fri, 29 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/003/18

Europe -DG Health and Food Safety

12-6-2018

EU/3/10/811 (Celgene Europe B.V.)

EU/3/10/811 (Celgene Europe B.V.)

EU/3/10/811 (Active substance: N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate) - Transfer of orphan designation - Commission Decision (2018)3809 of Tue, 12 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/092/10/T/03

Europe -DG Health and Food Safety

12-6-2018

EU/3/10/810 (Celgene Europe B.V.)

EU/3/10/810 (Celgene Europe B.V.)

EU/3/10/810 (Active substance: N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate) - Transfer of orphan designation - Commission Decision (2018)3808 of Tue, 12 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/084/10/T/03

Europe -DG Health and Food Safety

12-6-2018

EU/3/10/794 (Celgene Europe B.V.)

EU/3/10/794 (Celgene Europe B.V.)

EU/3/10/794 (Active substance: N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate) - Transfer of orphan designation - Commission Decision (2018)3803 of Tue, 12 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/069/10/T/03

Europe -DG Health and Food Safety

29-5-2018

EU/3/18/2026 (Alnylam UK Limited)

EU/3/18/2026 (Alnylam UK Limited)

EU/3/18/2026 (Active substance: Synthetic double-stranded siRNA oligonucleotide targeted against transthyretin mRNA, with six phosphorothioate linkages in the backbone, and nine 2'-fluoro and thirty-five 2'-O-methyl nucleoside residues in the sequence, which is covalently linked via a phosphodiester group to a ligand containing three N-acetylgalactosamine residues) - Orphan designation - Commission Decision (2018)3394 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/019/18

Europe -DG Health and Food Safety

29-5-2018

EU/3/18/2025 (Pharma Gateway AB)

EU/3/18/2025 (Pharma Gateway AB)

EU/3/18/2025 (Active substance: Modified mRNA encoding human methylmalonyl-coenzyme A mutase encapsulated into lipid nanoparticles) - Orphan designation - Commission Decision (2018)3393 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/017/18

Europe -DG Health and Food Safety

29-5-2018

EU/3/18/2019 (Dr Stefan Blesse)

EU/3/18/2019 (Dr Stefan Blesse)

EU/3/18/2019 (Active substance: Bardoxolone methyl) - Orphan designation - Commission Decision (2018)3386 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/011/18

Europe -DG Health and Food Safety

21-5-2018

EU/3/09/715 (Incyte Biosciences Distribution B.V.)

EU/3/09/715 (Incyte Biosciences Distribution B.V.)

EU/3/09/715 (Active substance: Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]) - Transfer of orphan designation - Commission Decision (2018)3139 of Mon, 21 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/122/09/T/02

Europe -DG Health and Food Safety

21-5-2018

EU/3/09/716 (Incyte Biosciences Distribution B.V.)

EU/3/09/716 (Incyte Biosciences Distribution B.V.)

EU/3/09/716 (Active substance: Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]) - Transfer of orphan designation - Commission Decision (2018)3140 of Mon, 21 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/121/09/T/02

Europe -DG Health and Food Safety

3-4-2018

EU/3/12/1080 (AbbVie Deutschland GmbH and Co. KG)

EU/3/12/1080 (AbbVie Deutschland GmbH and Co. KG)

EU/3/12/1080 (Active substance: 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide) - Transfer of orphan designation - Commission Decision (2018)2056 of Tue, 03 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/124/12/T/01

Europe -DG Health and Food Safety

21-3-2018

EU/3/14/1363 (IQVIA RDS Ireland Limited)

EU/3/14/1363 (IQVIA RDS Ireland Limited)

EU/3/14/1363 (Active substance: 4-[[(1S,4S)-5-[[4-[4-(oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]hept-2-yl]methyl]benzoic acid) - Transfer of orphan designation - Commission Decision (2018)1818 of Wed, 21 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/131/14/T/01

Europe -DG Health and Food Safety

21-3-2018

EU/3/16/1714 (IQVIA RDS Ireland Limited)

EU/3/16/1714 (IQVIA RDS Ireland Limited)

EU/3/16/1714 (Active substance: 6'-(R)-methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)-paromamine sulfate) - Transfer of orphan designation - Commission Decision (2018)1823 of Wed, 21 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/119/16/T/01

Europe -DG Health and Food Safety